Cytodyn Inc. (CYDY) — DEF 14A Filings
All DEF 14A filings from Cytodyn Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
CytoDyn Seeks 28.57% Stock Authorization Hike Ahead of Annual Meeting
— Sep 29, 2025 Risk: high
CytoDyn Inc. is holding its 2025 Annual Meeting of Stockholders on November 21, 2025, virtually, to address several critical proposals. A key item is the electi -
CytoDyn Inc. Files Definitive Proxy Statement
— Oct 11, 2024 Risk: low
CytoDyn Inc. filed its definitive proxy statement on October 11, 2024, for its annual meeting on November 22, 2024. The company, previously known as Rexray Corp
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX